Career Breakfast Club and QA session with Dr John Ridden

John is a cofounder and CEO of Blueberry Therapeutics, a drug discovery and development company. Incorporated in 2011, they are focused on the development of nanomedicines to treat infection and inflammation. He is also cofounder and director of a London based Biotech company called Tecrea. Tecrea was set up in 2012 to commercialise nanotechnology platforms in the formulation of new medicines, and as tools for bioscience research. We would like to thank John for offering his time for the Q&A session to talk about his career.